期刊文献+

原发性皮肤弥漫性大B细胞淋巴瘤,腿型 被引量:2

A case of primary cutaneous diffuse large B-cell lymphoma,leg type
下载PDF
导出
摘要 报告1例原发性皮肤弥漫性大B细胞淋巴瘤,腿型。患者男,77岁。双小腿出现多个红褐色斑块和结节半年。皮损组织病理检查:肿瘤细胞无嗜表皮现象,表皮与真皮之间可见一条无细胞的透明带,真皮内可见较大的异形淋巴细胞样细胞浸润,肿瘤细胞体积大,大部分呈明显的圆形,细胞核大异形性明显,核分裂象易见。免疫组化:CD20(+)、CD79α(+)、B细胞淋巴瘤(B-cell lymphoma,Bcl)-2(+)、B细胞特异性激活蛋白(Pax)-5(+)、多发性骨髓瘤癌基因1(multiple myeloma oncogene 1,MUM1)(+)、肌酸激酶(CK)(-)、CD3(-)、Bcl-6(-)、CD10(-)、细胞周期素d1(Cyclin D-1)(-)、黑色素A(Melan A)(-)、CD7(-)、生长因子受体结合蛋白(Gr B)(-)、CD30(-)、CD56(-)、CD4(-)、CD8(-)及细胞核增殖抗原(Ki-67)约80%(+)。诊断:原发性皮肤弥漫性大B细胞性淋巴瘤,腿型。经过R-CHOP方案(环磷酰胺+表柔比星+长春新碱+泼尼松)化疗后,肿块明显退缩。 A case of primary cutaneous diffuse large B-cell lymphoma(leg type)is reported.A 77-year-old man manifested multiple red-brown plaques and nodules on the both low legs about half a year.Histopathologic examination revealed cell free zone between the epidermis and the dermis,large and atypical lymphoid cell infiltration in the dermis,but no epidermotropism.Majority of tumor cells are round with atypical nuclei and some with mitotic activity.Immunohistochemistry demonstrated CD20(+),CD79α(+),Bcl-2(+),Pax-5(+),Mum-1(+),CK(-),CD3(-),Bcl-6(-),CD10(-),Cyclin D-1(-),Melan A(-),CD7(-),Gr B(-),CD30(-),CD56(-),CD4(-),CD8(-)and Ki-67(+80%).The patient was diagnosed with primary cutaneous diffuse large B-cell lymphoma(leg type)After R-CHOP chemotherapy,the tumor size became smaller.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2016年第4期262-264,共3页 Journal of Clinical Dermatology
关键词 弥漫性大B细胞淋巴瘤 皮肤 原发性 large B-cell lymphoma skin primary
  • 相关文献

参考文献10

  • 1Florent G, Marie BB, PhiUipe 12, et al. Primary cutaneous diffuse large B--cell lymphoms, leg type elinicopathologic features and prognostic analysis in 60 cases[J]. Arch of Dermatol, 2007, 143(9):. 1144-1150.
  • 2Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105(10): 3768-3785.
  • 3夏云,陈柳青,陈龙,黄萌,陈金波,段逸群.原发性皮肤弥漫性大B细胞淋巴瘤[J].临床皮肤科杂志,2013,42(2):82-84. 被引量:4
  • 4Kodama K, Massone C, Chott A, et al. Primary cutaneous large B-- cell lymphomas:clinicopathologic features, classification, and prog- nostic factors in a large series of patients[J]. Blood. 2005, 106(7): 2491-3497.
  • 5Grange F, Bekkenk MW, Weehsler J, et at. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multi- center study[J]. J Clin Oncol, 2001, 19(16): 3602-3610.
  • 6Hatlermann C, Kaunc KM, C, esk S, et al. molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 geneloci in primary cutaneous large B-cell lym- phomas[J]. J Invest Dermatol, 2004, 123(1): 213-219.
  • 7刘洁,王涛,马东来,方凯,晋红中.原发性皮肤弥漫大B细胞淋巴瘤,腿型[J].临床皮肤科杂志,2008,37(11):702-704. 被引量:5
  • 8Belaud-Rotureau MA, Marietta V, Vergier B, et al. Inactivation of pl6INK4a/CDKIN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas[J]. Virchows Arch, 2008, 452(6): 607-620.
  • 9Senff NJ, Hoefnagel JJ, Neetis K J, et al. Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification[J~ Arch Dennatol, 2007, 143 (12): 1520-1526,.
  • 10Marion F, GaeIle Q, Anabelle B, et al. Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type[J]. Eur J Der- matol, 2010, 20(6): 735-737.

二级参考文献15

  • 1Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fun- goides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)[J]. Blood, 2007, 110(2): 479- 484.
  • 2Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105(10): 3768- 3785.
  • 3Zinzani PL, Quaglino P, Pimpinelli N, et al. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas[J]. J Clin Oncol, 2006, 24(9): 1376- 1382.
  • 4Kodama K, Massone C, Chott A, et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients[J]. Blood, 2005, 106(7): 2491-3497.
  • 5Grange F, Bekkenk MW, Wechsler J, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study[J]. J Clin Oncol, 2001, 19(16): 3602-3610.
  • 6Hoefnagel JJ, Dijkman R, Basso K, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling[J]. Blood, 2005, 105(9): 3671-3678.
  • 7Mao X, Lillington D, Child F, et al. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis[J]. Genes Chromosomes Cancer, 2002, 35(2): 144-155.
  • 8Grange F, Beylot-Barry M, Courville P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinieopathologie features and prognostic analysis in 60 cases [J]. Arch Dermatol, 2007, 143(9): 1144-1150.
  • 9Willemze R,Jaffe ES,Burg G. WHO-EORTC classification for cutaneous lymphomas[J].Blood,2005,(10):3768-3785.
  • 10FlorentG,Marie BB,Phillipe C. Primary.cutaneous diffuse large B-cell lymphoma,leg type clinicopathologic features and prognostic analysis in 60 cases[J].Arch of Dermatol,2007,(09):1144-1150.

共引文献7

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部